Current Protein Identity:P00441 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1AZV FAMILIAL ALS MUTANT G37R CUZNSOD (HUMAN) Deposited 1997-11-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:G37R Mutation:G37R CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5;20 MG/ML PROTEIN IN 10MM ACETATE PH 5.5 MIXED WITH PRECIPITATING SOLUTION OF 100 MM ACETATE PH 4.6, 2.0 M AMMONIUM SULFATE
Resolution 1.90 Å R-free 0.244
1BA9 THE SOLUTION STRUCTURE OF REDUCED MONOMERIC SUPEROXIDE DISMUTASE, NMR, 36 STRUCTURES Deposited 1998-04-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–153(153 aa)
Mutation:C6A, F50E, G51E, C111S, E133Q ZN ZINC ION × 1 CU1 COPPER (I) ION × 1 SOLUTION NMR
NMR measurement conditions pH 5;298 K;Pressure 1
NMR sample composition H2O AND D2O
Resolution not provided
1DSW THE SOLUTION STRUCTURE OF A MONOMERIC, REDUCED FORM OF HUMAN COPPER, ZINC SUPEROXIDE DISMUTASE BEARING THE SAME CHARGE AS THE NATIVE PROTEIN Deposited 2000-01-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa) Fragment:;M4SOD IS A MONOMERIC VARIANT OF HUMAN SOD. THE MUTANT IS STUDIED IN THE REDUCED FORM, EACH MOLECULE CONTAINS A CU(I) AND A ZN(II) IONS. ;
Mutation:YES CU COPPER (II) ION × 1 ZN ZINC ION × 1 SOLUTION NMR
NMR measurement conditions pH 5;298 K;Pressure ATMOSPHERIC
NMR sample composition 2MM M4SOD FULLY ENRICHED IN 15N; 20MM PHOSPHATE BUFFER PH 5.0; 90% H2O, 10% D2O. THE PROTEIN WAS REDUCED WITH SODIUM ISOASCORBATE UNDER UNAEROBIC CONDITIONS.
Resolution not provided
1FUN SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) Deposited 1998-07-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Mutation:C6A, C111S, K136E Mutation:C6A, C111S, K136E CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;pH 7.0
Resolution 2.85 Å
1FUN SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) Deposited 1998-07-23 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–153(153 aa)
Chain G 1–153(153 aa)
Mutation:C6A, C111S, K136E Mutation:C6A, C111S, K136E CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;pH 7.0
Resolution 2.85 Å
1FUN SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) Deposited 1998-07-23 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain H 1–153(153 aa)
Mutation:C6A, C111S, K136E Mutation:C6A, C111S, K136E CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;pH 7.0
Resolution 2.85 Å
1FUN SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) Deposited 1998-07-23 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–153(153 aa)
Chain I 1–153(153 aa)
Mutation:C6A, C111S, K136E Mutation:C6A, C111S, K136E CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;pH 7.0
Resolution 2.85 Å
1FUN SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) Deposited 1998-07-23 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain J 1–153(153 aa)
Mutation:C6A, C111S, K136E Mutation:C6A, C111S, K136E CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;pH 7.0
Resolution 2.85 Å
1HL4 The Structure of Apo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2M NH4CL, 20%PEG2000, 10% ETHYLENE GLYCOL, 0.1 M MES PH 5.6
Resolution 1.82 Å R-free 0.283
1HL4 The Structure of Apo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2M NH4CL, 20%PEG2000, 10% ETHYLENE GLYCOL, 0.1 M MES PH 5.6
Resolution 1.82 Å R-free 0.283
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain H 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 2–154(153 aa)
Chain I 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain J 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 2–154(153 aa)
Chain K 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain L 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 2–154(153 aa)
Chain M 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 7 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Chain N 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 8 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain O 2–154(153 aa)
Chain Q 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1HL5 The Structure of Holo Type Human Cu, Zn Superoxide Dismutase Deposited 2003-03-13 Assembly 9 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain P 2–154(153 aa)
Chain S 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2 M CA ACETATE, 15% PEG 3350, 0.1 M TRIS PH 8.0
Resolution 1.80 Å R-free 0.222
1KMG The Solution Structure Of Monomeric Copper-free Superoxide Dismutase Deposited 2001-12-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–153(153 aa)
Mutation:C6A, F50E, G51E, C111S, E133Q ZN ZINC ION × 1 SOLUTION NMR
NMR measurement conditions pH 5;298 K;Ionic strength (raw mmCIF value) 20 mM phosphate;Pressure 1
NMR sample composition 2mM of 15N and 13C enriched superoxide dismutase | 20mM phosphate buffer, 10% D20
NMR sample composition 2mM of 15N and 13C enriched superoxide dismutase | 20mM phosphate buffer, 10% D20
NMR sample composition 2mM unlabelled superoxide dismutase | 20mM phosphate buffer, 10% D20
Resolution not provided
1L3N The Solution Structure of Reduced Dimeric Copper Zinc SOD: the Structural Effects of Dimerization Deposited 2002-02-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SOLUTION NMR
NMR measurement conditions pH 5;296 K;Pressure 1
NMR measurement conditions pH 5;286 K;Pressure 1
NMR sample composition Cu(I),Zn(II) SOD 2mM enriched in 15N | 20mM phosphate buffer pH5.00 10% D2O, 8mM ascorbate reductant
NMR sample composition Cu(I),Zn(II) SOD 2mM enriched in 15N, 13C | 20mM phosphate buffer pH5.00 10% D2O, 8mM ascorbate reductant
NMR sample composition Cu(I),Zn(II) SOD 2mM enriched in 15N, 13C and 2H at 70% | 20mM phosphate buffer pH5.00 10% D2O, 8mM ascorbate reductant
NMR sample composition Cu(I),Zn(II) SOD 2mM enriched in 15N | 20mM phosphate buffer pH5.00 100% D2O, 8mM ascorbate reductant
Resolution not provided
1MFM MONOMERIC HUMAN SOD MUTANT F50E/G51E/E133Q AT ATOMIC RESOLUTION Deposited 1999-04-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–153(153 aa)
Mutation:C6A,F50E,G51E,C111S,E133Q ZN ZINC ION × 1 CU COPPER (II) ION × 1 CD CADMIUM ION × 9 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;PEG 6000 15%, CDCL2 200-400 MM, TRIS 100MM, PH=8, pH 8.0
Resolution 1.02 Å
1N18 Thermostable mutant of Human Superoxide Dismutase, C6A, C111S Deposited 2002-10-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 0–153(154 aa)
Chain B 0–153(154 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Ammonium Sulfate, NaCl, Tris, EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.250
1N18 Thermostable mutant of Human Superoxide Dismutase, C6A, C111S Deposited 2002-10-16 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 0–153(154 aa)
Chain D 0–153(154 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Ammonium Sulfate, NaCl, Tris, EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.250
1N18 Thermostable mutant of Human Superoxide Dismutase, C6A, C111S Deposited 2002-10-16 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 0–153(154 aa)
Chain F 0–153(154 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Ammonium Sulfate, NaCl, Tris, EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.250
1N18 Thermostable mutant of Human Superoxide Dismutase, C6A, C111S Deposited 2002-10-16 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 0–153(154 aa)
Chain H 0–153(154 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Ammonium Sulfate, NaCl, Tris, EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.250
1N18 Thermostable mutant of Human Superoxide Dismutase, C6A, C111S Deposited 2002-10-16 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 0–153(154 aa)
Chain J 0–153(154 aa)
Mutation:C6A, C111S Mutation:C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;Ammonium Sulfate, NaCl, Tris, EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.250
1N19 Structure of the HSOD A4V mutant Deposited 2002-10-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 0–153(154 aa)
Chain B 0–153(154 aa)
Mutation:A4V, C6A, C111S Mutation:A4V, C6A, C111S CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;ammonium sulfate, NaCl, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.86 Å R-free 0.260
1OEZ Zn His46Arg mutant of Human Cu, Zn Superoxide Dismutase Deposited 2003-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Y 1–153(153 aa)
Chain Z 1–153(153 aa)
Mutation:YES Mutation:YES ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2M NA2SO4, 15% PEG 3350, pH 8.00
Resolution 2.15 Å R-free 0.234
1OEZ Zn His46Arg mutant of Human Cu, Zn Superoxide Dismutase Deposited 2003-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain W 1–153(153 aa)
Chain X 1–153(153 aa)
Mutation:YES Mutation:YES ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;0.2M NA2SO4, 15% PEG 3350, pH 8.00
Resolution 2.15 Å R-free 0.234
1OZT Crystal Structure of apo-H46R Familial ALS Mutant human Cu,Zn Superoxide Dismutase (CuZnSOD) to 2.5A resolution Deposited 2003-04-09 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain M 1–153(153 aa)
Chain N 1–153(153 aa)
Mutation:H46R Mutation:H46R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;magnesium acetate, sodium cacodylate, PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.50 Å R-free 0.270
1OZT Crystal Structure of apo-H46R Familial ALS Mutant human Cu,Zn Superoxide Dismutase (CuZnSOD) to 2.5A resolution Deposited 2003-04-09 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–153(153 aa)
Chain H 1–153(153 aa)
Mutation:H46R Mutation:H46R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;magnesium acetate, sodium cacodylate, PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.50 Å R-free 0.270
1OZT Crystal Structure of apo-H46R Familial ALS Mutant human Cu,Zn Superoxide Dismutase (CuZnSOD) to 2.5A resolution Deposited 2003-04-09 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 1–153(153 aa)
Chain L 1–153(153 aa)
Mutation:H46R Mutation:H46R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;magnesium acetate, sodium cacodylate, PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.50 Å R-free 0.270
1OZT Crystal Structure of apo-H46R Familial ALS Mutant human Cu,Zn Superoxide Dismutase (CuZnSOD) to 2.5A resolution Deposited 2003-04-09 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–153(153 aa)
Chain J 1–153(153 aa)
Mutation:H46R Mutation:H46R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;magnesium acetate, sodium cacodylate, PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.50 Å R-free 0.270
1OZU Crystal Structure of Familial ALS Mutant S134N of human Cu,Zn Superoxide Dismutase (CuZnSOD) to 1.3A resolution Deposited 2003-04-09 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:S134N Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:S134N Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;Ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
Resolution 1.30 Å R-free 0.193
1P1V Crystal Structure of FALS-associated human Copper-Zinc Superoxide Dismutase (CuZnSOD) Mutant D125H to 1.4A Deposited 2003-04-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:D125H Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:D125H Non-standard monomer:Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;278 K;zinc sulfate, PEG MME 550, MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K
Resolution 1.40 Å R-free 0.212
1P1V Crystal Structure of FALS-associated human Copper-Zinc Superoxide Dismutase (CuZnSOD) Mutant D125H to 1.4A Deposited 2003-04-14 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Mutation:D125H Non-standard monomer:Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;278 K;zinc sulfate, PEG MME 550, MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K
Resolution 1.40 Å R-free 0.212
1PTZ Crystal structure of the human CU, Zn Superoxide Dismutase, Familial Amyotrophic Lateral Sclerosis (FALS) Mutant H43R Deposited 2003-06-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:C6A, C111S, H43R Mutation:C6A, C111S, H43R CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;294 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
Resolution 1.80 Å R-free 0.215
1PU0 Structure of Human Cu,Zn Superoxide Dismutase Deposited 2003-06-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Not recorded CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.243
1PU0 Structure of Human Cu,Zn Superoxide Dismutase Deposited 2003-06-23 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain D 1–153(153 aa)
Not recorded CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.243
1PU0 Structure of Human Cu,Zn Superoxide Dismutase Deposited 2003-06-23 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain F 1–153(153 aa)
Not recorded CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.243
1PU0 Structure of Human Cu,Zn Superoxide Dismutase Deposited 2003-06-23 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–153(153 aa)
Chain H 1–153(153 aa)
Not recorded CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.243
1PU0 Structure of Human Cu,Zn Superoxide Dismutase Deposited 2003-06-23 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–153(153 aa)
Chain J 1–153(153 aa)
Not recorded CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;ammonium sulphate, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.243
1RK7 Solution structure of apo Cu,Zn Superoxide Dismutase: role of metal ions in protein folding Deposited 2003-11-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–153(153 aa)
Mutation:C6A, F50E, G51E, C111S, E133Q No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 5;298 K;Pressure 1
NMR sample composition Apo SOD 2mM | 20mM phosphate buffer pH5.0, 10% D2O
NMR sample composition Apo SOD 2mM enriched in 15N | 20mM phosphate buffer pH5.0, 10% D2O
NMR sample composition Apo SOD 2mM enriched in 15N and 13C | 20mM phosphate buffer pH5.0, 10% D2O
Resolution not provided
1SOS ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE Deposited 1992-02-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1SOS ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE Deposited 1992-02-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–153(153 aa)
Chain G 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1SOS ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE Deposited 1992-02-11 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain H 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1SOS ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE Deposited 1992-02-11 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–153(153 aa)
Chain I 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1SOS ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE Deposited 1992-02-11 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain J 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1SPD AMYOTROPHIC LATERAL SCLEROSIS AND STRUCTURAL DEFECTS IN CU,ZN SUPEROXIDE DISMUTASE Deposited 1993-07-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
1UXL I113T mutant of human SOD1 Deposited 2004-02-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;100 MM NACL, 2.4M AMMONIUM SULPHATE PH 7.5
Resolution 1.60 Å R-free 0.196
1UXL I113T mutant of human SOD1 Deposited 2004-02-25 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–153(153 aa)
Chain G 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;100 MM NACL, 2.4M AMMONIUM SULPHATE PH 7.5
Resolution 1.60 Å R-free 0.196
1UXL I113T mutant of human SOD1 Deposited 2004-02-25 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain H 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;100 MM NACL, 2.4M AMMONIUM SULPHATE PH 7.5
Resolution 1.60 Å R-free 0.196
1UXL I113T mutant of human SOD1 Deposited 2004-02-25 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–153(153 aa)
Chain I 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;100 MM NACL, 2.4M AMMONIUM SULPHATE PH 7.5
Resolution 1.60 Å R-free 0.196
1UXL I113T mutant of human SOD1 Deposited 2004-02-25 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain J 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;100 MM NACL, 2.4M AMMONIUM SULPHATE PH 7.5
Resolution 1.60 Å R-free 0.196
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain D 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain F 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–153(153 aa)
Chain H 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–153(153 aa)
Chain J 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
1UXM A4V mutant of human SOD1 Deposited 2004-02-26 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 1–153(153 aa)
Chain L 1–153(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;0.2 M CA ACET, 15% PEG 2000, 0.1 M TRIS PH 8.0
Resolution 1.90 Å R-free 0.250
2AF2 Solution structure of disulfide reduced and copper depleted Human Superoxide Dismutase Deposited 2005-07-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:C6A, C111S Mutation:C6A, C111S ZN ZINC ION × 2 SOLUTION NMR
NMR measurement conditions pH 5;298 K;Ionic strength (raw mmCIF value) 20mM sodium phosphate;Pressure 1
NMR sample composition 1.5mM 15N protein sample | 20mM sodium phosphate, 20mM DTT buffer, pH 5, 90% H2O, 10% D2O
NMR sample composition 1mM 15N;13C protein sample | 20mM sodium phosphate, 20mM DTT buffer, pH 5, 90% H2O, 10% D2O
NMR sample composition 1mM 15N;13C;2H protein sample. The triple labeled dimeric SOD contained about 70% 2H | 20mM sodium phosphate, 20mM DTT, buffer, pH 5, 90% H2O, 10% D2O
Resolution not provided
2C9S 1.24 Angstroms resolution structure of Zn-Zn Human Superoxide dismutase Deposited 2005-12-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 6 ACT ACETATE ION × 3 SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;2.5M AMMONIUM SULPHATE,0.1M NACL,50MM ACETATE BUFFER, pH 4.75
Resolution 1.24 Å R-free 0.194
2C9U 1.24 Angstroms resolution structure of as-isolated Cu-Zn Human Superoxide dismutase Deposited 2005-12-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Not recorded SO4 SULFATE ION × 3 CU COPPER (II) ION × 2 ZN ZINC ION × 4 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;3.0 M AMMONIUM SULPHATE, 100 MM SODIUM CHLORITE, 50MM SODIUM ACETATE BUFFER, pH 8.00
Resolution 1.24 Å R-free 0.176
2C9V Atomic resolution structure of Cu-Zn Human Superoxide dismutase Deposited 2005-12-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 5 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;3.0M AMMONIUM SULPHATE, 0.1M NACL, 50MM ACETATE BUFFER, pH 4.75
Resolution 1.07 Å R-free 0.158
2GBT C6A/C111A CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:C6A/C111A Mutation:C6A/C111A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;18% PEG8000, 50mM TRIS-HCL, 50mM NaAc, 1mM EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 1.70 Å R-free 0.230
2GBT C6A/C111A CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain D 1–153(153 aa)
Mutation:C6A/C111A Mutation:C6A/C111A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;18% PEG8000, 50mM TRIS-HCL, 50mM NaAc, 1mM EDTA, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 1.70 Å R-free 0.230
2GBU C6A/C111A/C57A/C146A apo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;25% PEG4000, 0.1M Na Cacodylate, 50mM NaAc, 1mM EDTA, 1mM NaN3, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.257
2GBU C6A/C111A/C57A/C146A apo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain D 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;25% PEG4000, 0.1M Na Cacodylate, 50mM NaAc, 1mM EDTA, 1mM NaN3, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.257
2GBV C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;2.8M Ammonium Sulphate, 50mM NaAc, 0.1M TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.207
2GBV C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–153(153 aa)
Chain G 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;2.8M Ammonium Sulphate, 50mM NaAc, 0.1M TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.207
2GBV C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain H 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;2.8M Ammonium Sulphate, 50mM NaAc, 0.1M TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.207
2GBV C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–153(153 aa)
Chain I 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;2.8M Ammonium Sulphate, 50mM NaAc, 0.1M TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.207
2GBV C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase Deposited 2006-03-11 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–153(153 aa)
Chain J 1–153(153 aa)
Mutation:C6A/C111A/C57A/C146A Mutation:C6A/C111A/C57A/C146A CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;2.8M Ammonium Sulphate, 50mM NaAc, 0.1M TRIS-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
Resolution 2.00 Å R-free 0.207
2LU5 Structure and chemical shifts of Cu(I),Zn(II) superoxide dismutase by solid-state NMR Deposited 2012-06-08 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:C6A, C111S CU COPPER (II) ION × 1 SOLID-STATE NMR
NMR measurement conditions pH 5;286 K;Ionic strength (raw mmCIF value) 0.02;Pressure ambient
NMR sample composition 3.5 mg [U-13C; U-15N; U-2H] Superoxide dismutase C6A/C111S thermostable mutant, 20 mM Sodium Citrate, 20% w/v Polyethylene Glycol 6000, 100% H2O | 100% H2O
Resolution not provided
2MP3 Truncated L126Z-sod1 in DPC micelle Deposited 2014-05-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–126(125 aa) Fragment:UNP residues 2-126
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 4;313 K;Pressure ambient
NMR sample composition 20 mM dodecylphosphocholine (DPC)-1, 400 uM [U-100% 13C; U-100% 15N] protein-2, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2NAM Full-length WT SOD1 in DPC MICELLE Deposited 2016-01-06 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 4;313 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition 20 mM DPC-1, 0.4 mM [U-13C; U-15N] entity-2, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2NNX Crystal Structure of the H46R, H48Q double mutant of human [Cu-Zn] Superoxide Dismutase Deposited 2006-10-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain B 1–153(153 aa)
Mutation:H46R, H48Q Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:H46R, H48Q Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.8;298 K;25% PEG 550MME, 0.1M MES, 0.01M zinc sulfate, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.30 Å R-free 0.241
2NNX Crystal Structure of the H46R, H48Q double mutant of human [Cu-Zn] Superoxide Dismutase Deposited 2006-10-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–153(153 aa)
Chain D 1–153(153 aa)
Mutation:H46R, H48Q Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:H46R, H48Q Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 4 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.8;298 K;25% PEG 550MME, 0.1M MES, 0.01M zinc sulfate, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.30 Å R-free 0.241
2R27 Constitutively zinc-deficient mutant of human superoxide dismutase (SOD), C6A, H80S, H83S, C111S Deposited 2007-08-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Mutation:C7A, H81S, D84S, C112S Mutation:C7A, H81S, D84S, C112S CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;2.45 M ammonium sulfate, 200 mM NaCl in 50 mM Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.00 Å R-free 0.246
2V0A Atomic resolution crystal structure of Human Superoxide Dismutase Deposited 2007-05-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–153(153 aa)
Chain F 1–153(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 3 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;3.5 M AMMONIUM SULPHATE, 100MM NACL, 50MM ACETATE BUFFER PH 4.75
Resolution 1.15 Å R-free 0.206
2VR6 Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.3 A resolution Deposited 2008-03-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:RESIDUES 2-154
Chain F 2–154(153 aa) Fragment:RESIDUES 2-154
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 4 SO4 SULFATE ION × 2 SCN THIOCYANATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;20% P3350 0.2 M NA THYOCYANATE, pH 7.0
Resolution 1.30 Å R-free 0.182
2VR7 Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.58 A resolution Deposited 2008-03-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:RESIDUES 2-154
Chain F 2–154(153 aa) Fragment:RESIDUES 2-154
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 6 SO4 SULFATE ION × 2 SCN THIOCYANATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;20% PEG3350, 0.2M SODIUM THIOCYANATE, pH 7.0
Resolution 1.58 Å R-free 0.175
2VR8 Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.36 A resolution Deposited 2008-03-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:RESIDUES 2-154
Chain F 2–154(153 aa) Fragment:RESIDUES 2-154
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 6 SO4 SULFATE ION × 2 SCN THIOCYANATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7;20% PEG3350, 0.2M SODIUM THIOCYANATE, pH 7.0
Resolution 1.36 Å R-free 0.153
2WKO Structure of metal loaded Pathogenic SOD1 Mutant G93A. Deposited 2009-06-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:RESIDUES 2-154
Chain F 2–154(153 aa) Fragment:RESIDUES 2-154
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 IOD IODIDE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;20% P3350, 0.2 M AMMONIUM IODIDE, pH 6.5
Resolution 1.97 Å R-free 0.231
2WYT 1.0 A resolution structure of L38V SOD1 mutant Deposited 2009-11-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 4 SO4 SULFATE ION × 6 ACT ACETATE ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;150 MM NACL, 2-3M AMMONIUM SULPHATE, 100 MM NA ACETATE BUFFER PH 4.75
Resolution 1.00 Å R-free 0.147
2WYZ L38V SOD1 mutant complexed with UMP Deposited 2009-11-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 4 CU COPPER (II) ION × 2 SO4 SULFATE ION × 4 U5P URIDINE-5'-MONOPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;150 MM NACL, 3.0 M AMMONIUM SULPHATE, 100 MM TRIS PH 7.5
Resolution 1.70 Å R-free 0.239
2WZ0 L38V SOD1 mutant complexed with aniline. Deposited 2009-11-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 3 SO4 SULFATE ION × 2 ZZT 2-METHOXY-5-METHYLANILINE × 2 DMS DIMETHYL SULFOXIDE × 1 DSN D-SERINE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;150 MM NACL,3.0 M AMMONIUM SULPHATE, 100 MM TRIS-HCL PH 7.5
Resolution 1.72 Å R-free 0.260
2WZ5 L38V SOD1 mutant complexed with L-methionine. Deposited 2009-11-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES ZN ZINC ION × 3 CU COPPER (II) ION × 2 SO4 SULFATE ION × 3 MET METHIONINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;150 MM NACL, 2.0-3.0 M AMMONIUM SULPHATE, 100 MM ACETATE BUFFER PH 4.75
Resolution 1.50 Å R-free 0.255
2WZ6 G93A SOD1 mutant complexed with Quinazoline. Deposited 2009-11-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES ZN ZINC ION × 4 CU COPPER (II) ION × 2 ZO0 4-(4-METHYL-1,4-DIAZEPAN-1-YL)-2-(TRIFLUOROMETHYL)QUINAZOLINE × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.75;150 MM NACL, 2.0-3.0 M AMMONIUM SULPHATE, 100 MM ACETATE BUFFER PH 4.75
Resolution 1.55 Å R-free 0.248
2XJK Monomeric Human Cu,Zn Superoxide dismutase Deposited 2010-07-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:YES CU COPPER (II) ION × 1 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6;25% PEG 6000, 0.1M MES (PH 6.0), 0.01M ZNCL2
Resolution 1.45 Å R-free 0.199
2XJL Monomeric Human Cu,Zn Superoxide dismutase without Cu ligands Deposited 2010-07-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:YES ZN ZINC ION × 4 PEG DI(HYDROXYETHYL)ETHER × 1 NA SODIUM ION × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;25% PEG 6000, 0.1M SODIUM ACETATE (PH 5.0), 0.01M ZNCL2
Resolution 1.55 Å R-free 0.183
2ZKW Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group P21 Deposited 2008-03-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Mutation:G85R Mutation:G85R CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.2;293 K;0.2M Ammonium iodide, 20%(w/v) PEG3350, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 1.90 Å R-free 0.252
2ZKX Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group I212121 Deposited 2008-03-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Mutation:G85R Mutation:G85R CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1M Sodium Acetate(pH 4.6), 1.5M Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.72 Å R-free 0.246
2ZKX Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group I212121 Deposited 2008-03-31 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Mutation:G85R Mutation:G85R CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1M Sodium Acetate(pH 4.6), 1.5M Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.72 Å R-free 0.246
2ZKY Crystal structure of human Cu-Zn superoxide dismutase mutant G93A Deposited 2008-03-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.40 Å R-free 0.235
2ZKY Crystal structure of human Cu-Zn superoxide dismutase mutant G93A Deposited 2008-03-31 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.40 Å R-free 0.235
2ZKY Crystal structure of human Cu-Zn superoxide dismutase mutant G93A Deposited 2008-03-31 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.40 Å R-free 0.235
2ZKY Crystal structure of human Cu-Zn superoxide dismutase mutant G93A Deposited 2008-03-31 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–154(154 aa)
Chain H 1–154(154 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.40 Å R-free 0.235
2ZKY Crystal structure of human Cu-Zn superoxide dismutase mutant G93A Deposited 2008-03-31 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M Cacodylate(pH 6.5), 0.2M NaCl, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.40 Å R-free 0.235
3CQP Human SOD1 G85R Variant, Structure I Deposited 2008-04-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.95 Å R-free 0.223
3CQP Human SOD1 G85R Variant, Structure I Deposited 2008-04-03 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 MLI MALONATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.95 Å R-free 0.223
3CQQ Human SOD1 G85R Variant, Structure II Deposited 2008-04-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 3 ACE ACETYL GROUP × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.90 Å R-free 0.240
3ECU Crystal structure of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;289.1 K;0.1 M MES 20% PEG 3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 1.90 Å R-free 0.279
3ECU Crystal structure of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;289.1 K;0.1 M MES 20% PEG 3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 1.90 Å R-free 0.279
3ECV Crystal structure of the ALS-related pathological mutant I113T of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;289.1 K;0.1 M MES 20% PEG 3350 , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 1.90 Å R-free 0.277
3ECV Crystal structure of the ALS-related pathological mutant I113T of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;289.1 K;0.1 M MES 20% PEG 3350 , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 1.90 Å R-free 0.277
3ECW Crystal structure of the ALS-related pathological mutant T54R of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;289.1 K;0.1 M HEPES 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 2.15 Å R-free 0.297
3ECW Crystal structure of the ALS-related pathological mutant T54R of human apo Cu,Zn Superoxide Dismutase (SOD1) Deposited 2008-09-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;289.1 K;0.1 M HEPES 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289.1K
Resolution 2.15 Å R-free 0.297
3GQF Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q Deposited 2009-03-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:H46R, H48Q Mutation:H46R, H48Q ZN ZINC ION × 2 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;297 K;20% polyethylene glycol 1000, imidazole pH 8.0, calcium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 297K
Resolution 2.20 Å R-free 0.242
3GQF Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q Deposited 2009-03-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Mutation:H46R, H48Q Mutation:H46R, H48Q ZN ZINC ION × 2 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;297 K;20% polyethylene glycol 1000, imidazole pH 8.0, calcium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 297K
Resolution 2.20 Å R-free 0.242
3GQF Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q Deposited 2009-03-24 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:H46R, H48Q Mutation:H46R, H48Q ZN ZINC ION × 2 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;297 K;20% polyethylene glycol 1000, imidazole pH 8.0, calcium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 297K
Resolution 2.20 Å R-free 0.242
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain B 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 2 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain D 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 3 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain F 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 4 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain H 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 5 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain J 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GTV Human-mouse SOD1 chimera Deposited 2009-03-28 Assembly 6 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Chain L 2–81(80 aa) Fragment:residues 2-81 from human protein, residues 82-154 from mouse protein
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;298 K;0.1 m HEPES, 25% PEG 8000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.20 Å R-free 0.231
3GZO HUMAN SOD1 G93A Variant Deposited 2009-04-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;2.4 M sodium malonate, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.214
3GZO HUMAN SOD1 G93A Variant Deposited 2009-04-07 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;2.4 M sodium malonate, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.214
3GZO HUMAN SOD1 G93A Variant Deposited 2009-04-07 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;2.4 M sodium malonate, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.214
3GZO HUMAN SOD1 G93A Variant Deposited 2009-04-07 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Chain H 2–154(153 aa)
Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 MLI MALONATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;2.4 M sodium malonate, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.214
3GZO HUMAN SOD1 G93A Variant Deposited 2009-04-07 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain J 2–154(153 aa)
Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:G93A Non-standard monomer:Yes (specific site not provided by mmCIF) CU COPPER (II) ION × 2 ZN ZINC ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;2.4 M sodium malonate, pH 6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.214
3GZP HUMAN SOD1 G93A Metal-free Variant Deposited 2009-04-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:G93A Mutation:G93A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M ammonium sulfate, 0.1 M HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 3.10 Å R-free 0.248
3GZP HUMAN SOD1 G93A Metal-free Variant Deposited 2009-04-07 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Mutation:G93A Mutation:G93A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M ammonium sulfate, 0.1 M HEPES, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 3.10 Å R-free 0.248
3GZQ HUMAN SOD1 A4V Metal-free Variant Deposited 2009-04-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:A4V Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:A4V Non-standard monomer:Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;1.6 M ammonium sulfate, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.40 Å R-free 0.193
3H2P Human SOD1 D124V Variant Deposited 2009-04-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:D124V Mutation:D124V ZN ZINC ION × 3 MLI MALONATE ION × 2 ACE ACETYL GROUP × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.4 M sodium malonate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.55 Å R-free 0.202
3H2Q Human SOD1 H80R variant, P21 crystal form Deposited 2009-04-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:H80R Mutation:H80R ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;2.3 M AMMONIUM SULFATE, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.85 Å R-free 0.222
3H2Q Human SOD1 H80R variant, P21 crystal form Deposited 2009-04-14 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Mutation:H80R Mutation:H80R ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;2.3 M AMMONIUM SULFATE, 0.1 M Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.85 Å R-free 0.222
3HFF Monomeric human Cu,Zn Superoxide dismutase without Zn ligands Deposited 2009-05-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:C6A, C111A, F50E, G51E, H63S, H71S, H80S, D83S ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;16% PEG 6000, 10% Jeffamine M-600 (pH 7.0), 0.1M Tris-HCl (pH 8.0), 0.1M ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.20 Å R-free 0.281
3HFF Monomeric human Cu,Zn Superoxide dismutase without Zn ligands Deposited 2009-05-11 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:C6A, C111A, F50E, G51E, H63S, H71S, H80S, D83S ZN ZINC ION × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;16% PEG 6000, 10% Jeffamine M-600 (pH 7.0), 0.1M Tris-HCl (pH 8.0), 0.1M ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.20 Å R-free 0.281
3K91 Polysulfane Bridge in Cu-Zn Superoxide Dismutase Deposited 2009-10-15 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:H46R, H48Q Mutation:H46R, H48Q PS5 PENTASULFIDE-SULFUR × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.6;298 K;0.17 M ammonium sulfate, 0.085 M sodium acetate, 25.5% PEG 4000, 15% glycerol, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 1.75 Å R-free 0.218
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Chain H 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain J 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH3 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit Deposited 2009-10-30 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 2–154(153 aa)
Chain L 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.277
3KH4 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P6522 crystal form containing 6 chains in the asymmetric unit Deposited 2009-10-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.208
3KH4 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P6522 crystal form containing 6 chains in the asymmetric unit Deposited 2009-10-30 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.208
3KH4 Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P6522 crystal form containing 6 chains in the asymmetric unit Deposited 2009-10-30 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;292 K;21-25% (w/v) PEG4000, 0.1 M NaOAc, pH 4.2-5.2, vapor diffusion, hanging drop, temperature 292K
Resolution 3.50 Å R-free 0.208
3LTV Mouse-human sod1 chimera Deposited 2010-02-16 Assembly 1 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Chain B 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.1 M SODIUM ACETATE, 25% PEG 4000, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.45 Å R-free 0.265
3LTV Mouse-human sod1 chimera Deposited 2010-02-16 Assembly 2 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Chain D 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.1 M SODIUM ACETATE, 25% PEG 4000, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.45 Å R-free 0.265
3LTV Mouse-human sod1 chimera Deposited 2010-02-16 Assembly 3 Insufficient information Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Chain F 82–154(73 aa) Fragment:;RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN,RESIDUES 2-81 FROM MOUSE PROTEIN, RESIDUES 82-154 FROM HUMAN PROTEIN ;
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.1 M SODIUM ACETATE, 25% PEG 4000, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.45 Å R-free 0.265
3QQD Human SOD1 H80R variant, P212121 crystal form Deposited 2011-02-15 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:YES Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;2.3 M AMMONIUM SULFATE, 0.1 M TRIS, TEMPERATURE 298K, pH 8.0, VAPOR DIFFUSION, HANGING DROP
Resolution 1.65 Å R-free 0.183
3RE0 Crystal structure of human apo Cu,Zn superoxide dismutase (SOD1) complexed with cisplatin Deposited 2011-04-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CPT Cisplatin × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;20% PEG 3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 2.28 Å R-free 0.290
3RE0 Crystal structure of human apo Cu,Zn superoxide dismutase (SOD1) complexed with cisplatin Deposited 2011-04-02 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded CPT Cisplatin × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;20% PEG 3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
Resolution 2.28 Å R-free 0.290
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 2–154(153 aa)
Chain E 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 2–154(153 aa)
Chain G 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain H 2–154(153 aa)
Chain I 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 2–154(153 aa)
Chain K 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
3T5W 2ME modified human SOD1 Deposited 2011-07-28 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain L 2–154(153 aa)
Chain M 2–154(153 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) CU1 COPPER (I) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
Resolution 1.80 Å R-free 0.241
4A7G Structure of human I113T SOD1 mutant complexed with 4-methylpiperazin- 1-yl)quinazoline in the p21 space group. Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES SO4 SULFATE ION × 5 12I 4-(4-METHYLPIPERAZIN-1-YL)QUINAZOLINE × 3 CU COPPER (II) ION × 2 ZN ZINC ION × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 M AMMONIUM SULPHATE
Resolution 1.24 Å R-free 0.175
4A7Q Structure of human I113T SOD1 mutant complexed with 4-(4-methyl-1,4- diazepan-1-yl)quinazoline in the p21 space group. Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES 4MQ 4-(4-METHYL-1,4-DIAZEPAN-1-YL)QUINAZOLINE × 2 SO4 SULFATE ION × 6 CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100 MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE
Resolution 1.22 Å R-free 0.159
4A7S Structure of human I113T SOD1 mutant complexed with 5-Fluorouridine in the p21 space group Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 5 ACT ACETATE ION × 2 5UD 5-FLUOROURIDINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE PH 5
Resolution 1.06 Å R-free 0.200
4A7T Structure of human I113T SOD1 mutant complexed with isoproteranol in the p21 space group Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES 5FW ISOPRENALINE × 5 SO4 SULFATE ION × 4 ACT ACETATE ION × 2 CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100 MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE
Resolution 1.45 Å R-free 0.188
4A7U Structure of human I113T SOD1 complexed with adrenaline in the p21 space group. Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES ALE L-EPINEPHRINE × 2 SO4 SULFATE ION × 4 CU COPPER (II) ION × 2 ZN ZINC ION × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE PH 5
Resolution 0.98 Å R-free 0.153
4A7V Structure of human I113T SOD1 mutant complexed with dopamine in the p21 space group Deposited 2011-11-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:YES Mutation:YES LDP L-DOPAMINE × 1 SO4 SULFATE ION × 4 CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5;100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 M AMMONIUM SULPHATE PH 5
Resolution 1.00 Å R-free 0.181
4B3E Structure of copper-zinc superoxide dismutase complexed with bicarbonate. Deposited 2012-07-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CO3 CARBONATE ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL
Resolution 2.15 Å R-free 0.215
4B3E Structure of copper-zinc superoxide dismutase complexed with bicarbonate. Deposited 2012-07-23 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–154(154 aa)
Chain G 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CO3 CARBONATE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL
Resolution 2.15 Å R-free 0.215
4B3E Structure of copper-zinc superoxide dismutase complexed with bicarbonate. Deposited 2012-07-23 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CO3 CARBONATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL
Resolution 2.15 Å R-free 0.215
4B3E Structure of copper-zinc superoxide dismutase complexed with bicarbonate. Deposited 2012-07-23 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–154(154 aa)
Chain I 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CO3 CARBONATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL
Resolution 2.15 Å R-free 0.215
4B3E Structure of copper-zinc superoxide dismutase complexed with bicarbonate. Deposited 2012-07-23 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 CO3 CARBONATE ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL
Resolution 2.15 Å R-free 0.215
4BCY Monomeric Human Cu,Zn Superoxide dismutase, mutation H43F Deposited 2012-10-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:YES CU COPPER (II) ION × 2 ZN ZINC ION × 1 CD CADMIUM ION × 6 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions 293 K;25% PEG 400, 0.1M NA ACETATE PH 4.6, 0.1 M CDCL2, 20 C
Resolution 1.27 Å R-free 0.203
4BCZ Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form. Deposited 2012-10-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–49(48 aa) Fragment:RESIDUES 2049,83-124,141-154
Chain A 83–124(42 aa) Fragment:RESIDUES 2049,83-124,141-154
Chain A 141–154(14 aa) Fragment:RESIDUES 2049,83-124,141-154
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 293 K;30% PEG 1500, 0.1M MIB BUFFER, PH 4.0, 20 C
Resolution 1.93 Å R-free 0.220
4BCZ Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form. Deposited 2012-10-03 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–49(48 aa) Fragment:RESIDUES 2049,83-124,141-154
Chain B 83–124(42 aa) Fragment:RESIDUES 2049,83-124,141-154
Chain B 141–154(14 aa) Fragment:RESIDUES 2049,83-124,141-154
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 293 K;30% PEG 1500, 0.1M MIB BUFFER, PH 4.0, 20 C
Resolution 1.93 Å R-free 0.220
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–49(48 aa)
Chain A 83–124(42 aa)
Chain A 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–49(48 aa)
Chain B 83–124(42 aa)
Chain B 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 2–49(48 aa)
Chain C 83–124(42 aa)
Chain C 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 2–49(48 aa)
Chain D 83–124(42 aa)
Chain D 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain E 2–49(48 aa)
Chain E 83–124(42 aa)
Chain E 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain F 2–49(48 aa)
Chain F 83–124(42 aa)
Chain F 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain G 2–49(48 aa)
Chain G 83–124(42 aa)
Chain G 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 8 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain H 2–49(48 aa)
Chain H 83–124(42 aa)
Chain H 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4BD4 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F Deposited 2012-10-04 Assembly 9 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain I 2–49(48 aa)
Chain I 83–124(42 aa)
Chain I 141–154(14 aa)
Mutation:YES Mutation:YES Mutation:YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions 18 % PEG 1500, 15% GLYCEROL
Resolution 2.78 Å R-free 0.246
4FF9 Crystal Structure of cysteinylated WT SOD1. Deposited 2012-05-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CYS CYSTEINE × 1 ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.25;298 K;0.1M MES, pH 6.25, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.50 Å R-free 0.335
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:UNP residues 2-154
Chain B 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa) Fragment:UNP residues 2-154
Chain D 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa) Fragment:UNP residues 2-154
Chain F 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa) Fragment:UNP residues 2-154
Chain H 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa) Fragment:UNP residues 2-154
Chain J 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCM Human SOD1 C57S Mutant, As-isolated Deposited 2013-08-21 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 2–154(153 aa) Fragment:UNP residues 2-154
Chain L 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S ZN ZINC ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;295 K;0.2 M ammonium sulfate, 0.1 M bis-tris, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.20 Å R-free 0.262
4MCN Human SOD1 C57S Mutant, Metal-free Deposited 2013-08-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa) Fragment:UNP residues 2-154
Chain B 2–154(153 aa) Fragment:UNP residues 2-154
Mutation:C57S Mutation:C57S SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;295 K;3.2 M ammonium sulfate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 2.60 Å R-free 0.245
4NIN DSVISLS segment 101-107 from Human Superoxide Dismutase Deposited 2013-11-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 102–108(7 aa) Fragment:UNP residues 102-108
Not recorded ZN ZINC ION × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;0.1 M MES pH 6.0, 20% PEG 6000, and 5 mM ZnCl2, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.40 Å R-free 0.228
4NIO GVTGIAQ segment 147-153 from Human Superoxide Dismutase with I149T mutation associated with a familial form of amyotrophic lateral sclerosis Deposited 2013-11-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 148–154(7 aa) Fragment:UNP Residues 148-154
Mutation:I149T No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M sodium acetate pH 4.5, 0.7 M hexanediol, vapor diffusion, hanging drop, temperature 298K
Resolution 1.30 Å R-free 0.233
4NIP GVIGIAQ segment 147-153 from Human Superoxide Dismutase Deposited 2013-11-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 148–154(7 aa) Fragment:UNP Residues 148-154
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;1 M sodium acetate pH 4.5, 1.75 M ammonium sulfate, vapor diffusion, hanging drop, temperature 298K
Resolution 1.90 Å R-free 0.248
4OH2 Crystal Structure of Cu/Zn Superoxide Dismutase I149T Deposited 2014-01-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:C6A, C111S, L149T Mutation:C6A, C111S, L149T CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;298 K;100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.38 Å R-free 0.216
4OH2 Crystal Structure of Cu/Zn Superoxide Dismutase I149T Deposited 2014-01-16 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain D 2–154(153 aa)
Mutation:C6A, C111S, L149T Mutation:C6A, C111S, L149T CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;298 K;100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.38 Å R-free 0.216
4OH2 Crystal Structure of Cu/Zn Superoxide Dismutase I149T Deposited 2014-01-16 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:C6A, C111S, L149T Mutation:C6A, C111S, L149T CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;298 K;100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.38 Å R-free 0.216
4OH2 Crystal Structure of Cu/Zn Superoxide Dismutase I149T Deposited 2014-01-16 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Chain H 2–154(153 aa)
Mutation:C6A, C111S, L149T Mutation:C6A, C111S, L149T CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;298 K;100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.38 Å R-free 0.216
4OH2 Crystal Structure of Cu/Zn Superoxide Dismutase I149T Deposited 2014-01-16 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain J 2–154(153 aa)
Mutation:C6A, C111S, L149T Mutation:C6A, C111S, L149T CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;298 K;100mM NaCl, 100mM Tris-HCl pH 7.6, 2.8M (NH4)2SO4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.38 Å R-free 0.216
4XCR Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant I35A Deposited 2014-12-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:I45A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5.5;293 K;0.1 M Bis Tris and 2.0 M ammonium sulfate
Resolution 3.60 Å R-free 0.239
4XCR Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant I35A Deposited 2014-12-18 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–154(153 aa)
Mutation:I45A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5.5;293 K;0.1 M Bis Tris and 2.0 M ammonium sulfate
Resolution 3.60 Å R-free 0.239
5DLI Corkscrew assembly of SOD1 residues 28-38 Deposited 2015-09-05 Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 29–39(11 aa) Fragment:Residues 29-39
Chain B 29–39(11 aa) Fragment:Residues 29-39
Chain C 29–39(11 aa) Fragment:Residues 29-39
Chain D 29–39(11 aa) Fragment:Residues 29-39
Chain E 29–39(11 aa) Fragment:Residues 29-39
Chain F 29–39(11 aa) Fragment:Residues 29-39
Chain G 29–39(11 aa) Fragment:Residues 29-39
Chain H 29–39(11 aa) Fragment:Residues 29-39
Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K GOL GLYCEROL × 1 IOD IODIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;reservoir contained 13% PEG 6000, 0.2M Sodium Citrate
Resolution 2.10 Å R-free 0.262
5IIW Corkscrew assembly of SOD1 residues 28-38 without potassium iodide Deposited 2016-03-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 29–39(11 aa) Fragment:UNP Residues 29-39
Chain B 29–39(11 aa) Fragment:UNP Residues 29-39
Chain C 29–39(11 aa) Fragment:UNP Residues 29-39
Chain D 29–39(11 aa) Fragment:UNP Residues 29-39
Chain E 29–39(11 aa) Fragment:UNP Residues 29-39
Chain F 29–39(11 aa) Fragment:UNP Residues 29-39
Chain G 29–39(11 aa) Fragment:UNP Residues 29-39
Chain H 29–39(11 aa) Fragment:UNP Residues 29-39
Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K Mutation:P29K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5;298 K;reservoir contained 13% PEG 6000, 0.2M Sodium Citrate
Resolution 2.00 Å R-free 0.252
5J07 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P1/2 Deposited 2016-03-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 14–49(36 aa)
Chain A 84–124(41 aa)
Chain A 141–154(14 aa)
Chain A 2–13(12 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5;293 K;0.1 M MIB buffer pH 5.0 25 % w/v PEG 1500
Resolution 2.00 Å R-free 0.231
5J07 Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P1/2 Deposited 2016-03-27 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 14–49(36 aa)
Chain B 84–124(41 aa)
Chain B 141–154(14 aa)
Chain B 2–13(12 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5;293 K;0.1 M MIB buffer pH 5.0 25 % w/v PEG 1500
Resolution 2.00 Å R-free 0.231
5J0C Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P2/3 Deposited 2016-03-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 29–49(21 aa)
Chain A 84–124(41 aa)
Chain A 2–26(25 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5;293 K;0.1 M MIB buffer pH 5.0 25 % w/v PEG 1500
Resolution 1.60 Å R-free 0.186
5J0C Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P2/3 Deposited 2016-03-28 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 29–49(21 aa)
Chain B 84–124(41 aa)
Chain B 2–26(25 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;pH 5;293 K;0.1 M MIB buffer pH 5.0 25 % w/v PEG 1500
Resolution 1.60 Å R-free 0.186
5J0F Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P4/5 Deposited 2016-03-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 83–124(42 aa)
Chain A 2–49(48 aa)
Not recorded GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;293 K;0.17 M ammonium sulfate, 25.5 % w/v PEG 4K, 15 % v/v Glycerol
Resolution 1.25 Å R-free 0.170
5J0F Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P4/5 Deposited 2016-03-28 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 83–124(42 aa)
Chain B 2–49(48 aa)
Not recorded GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions EVAPORATION;293 K;0.17 M ammonium sulfate, 25.5 % w/v PEG 4K, 15 % v/v Glycerol
Resolution 1.25 Å R-free 0.170
5J0G Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P7/8 Deposited 2016-03-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–124(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M di-ammonium hydrogen citrate, 20 % w/v PEG 3350
Resolution 2.50 Å R-free 0.235
5J0G Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P7/8 Deposited 2016-03-28 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2–124(123 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M di-ammonium hydrogen citrate, 20 % w/v PEG 3350
Resolution 2.50 Å R-free 0.235
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 10 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Q 2–154(153 aa)
Chain V 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 11 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain R 2–154(153 aa)
Chain U 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 12 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain S 2–154(153 aa)
Chain T 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Chain L 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 2–154(153 aa)
Chain K 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain J 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 2–154(153 aa)
Chain I 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Chain H 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 7 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain M 2–154(153 aa)
Chain N 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 8 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain O 2–154(153 aa)
Chain X 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5K02 Structure of human SOD1 with T2D mutation Deposited 2016-05-17 Assembly 9 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain P 2–154(153 aa)
Chain W 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;T2D was crystallized in a buffer of 2 M (NH4)2SO4, 0.1 M Sodium Cacodylate, 20% MPD and 10 mM ZnCl2 (pH 6.5) after a period of approximately 5 months.
Resolution 1.99 Å R-free 0.162
5O3Y SOD1 bound to Ebsulfur Deposited 2017-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded ZN ZINC ION × 4 9JK ~{N}-phenyl-2-sulfanyl-benzamide × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 3.75;293 K;100 mM NaAct pH 3.75, 100 mM NaCl, 2.8 M AmSO4
Resolution 1.30 Å R-free 0.186
5O40 SOD1 bound to Ebselen Deposited 2017-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded ZN ZINC ION × 4 9JT N-phenyl-2-selanylbenzamide × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4;293 K;100 mM NaACT pH 4, 2.4 M AMSO4, 150 mM NaCl
Resolution 1.50 Å R-free 0.215
5U9M Copper-Zinc Superoxide Dismutase is Activated through a Sulfenic Acid Intermediate at a Copper-ion Entry Site Deposited 2016-12-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:H46R,H48Q ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;298 K;25 % PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5
Resolution 2.35 Å R-free 0.235
5U9M Copper-Zinc Superoxide Dismutase is Activated through a Sulfenic Acid Intermediate at a Copper-ion Entry Site Deposited 2016-12-16 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Mutation:H46R,H48Q ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;298 K;25 % PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5
Resolution 2.35 Å R-free 0.235
5WMJ KVWGSI segment from Superoxide Dismutase 1,residues 30-35 Deposited 2017-07-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 31–36(6 aa) Fragment:UNP residues 31-36
Chain B 31–36(6 aa) Fragment:UNP residues 31-36
Not recorded TFA trifluoroacetic acid × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;Reservoir solution contained 4M Sodium Formate
Resolution 1.40 Å R-free 0.170
5WOR Corkscrew assembly of SOD1 residues 28-38 with familial mutation G37R Deposited 2017-08-02 Assembly 1 Protein homooligomer Homooligomer;Protein × 20 PDB declaration: eicosameric(20) Consistent with protein count
Chain A 29–39(11 aa) Fragment:UNP residues 29-39
Chain B 29–39(11 aa) Fragment:UNP residues 29-39
Chain C 29–39(11 aa) Fragment:UNP residues 29-39
Chain D 29–39(11 aa) Fragment:UNP residues 29-39
Chain E 29–39(11 aa) Fragment:UNP residues 29-39
Chain F 29–39(11 aa) Fragment:UNP residues 29-39
Chain G 29–39(11 aa) Fragment:UNP residues 29-39
Chain H 29–39(11 aa) Fragment:UNP residues 29-39
Chain I 29–39(11 aa) Fragment:UNP residues 29-39
Chain J 29–39(11 aa) Fragment:UNP residues 29-39
Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R Mutation:P29K,G38R MLI MALONATE ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;reservoir contained 15% PEG 3350, 0.3M Sodium Malonate
Resolution 2.77 Å R-free 0.247
5YTO Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound. Deposited 2017-11-19 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 946 4-[(1~{R})-2-(naphthalen-2-ylmethylamino)-1-oxidanyl-ethyl]benzene-1,2-diol × 1 PS5 PENTASULFIDE-SULFUR × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;sodium citrate, pH 6.0
Resolution 1.90 Å R-free 0.215
5YTO Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound. Deposited 2017-11-19 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 1 946 4-[(1~{R})-2-(naphthalen-2-ylmethylamino)-1-oxidanyl-ethyl]benzene-1,2-diol × 1 PS5 PENTASULFIDE-SULFUR × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;sodium citrate, pH 6.0
Resolution 1.90 Å R-free 0.215
5YTO Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound. Deposited 2017-11-19 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded ZN ZINC ION × 2 PS5 PENTASULFIDE-SULFUR × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;sodium citrate, pH 6.0
Resolution 1.90 Å R-free 0.215
5YTO Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound. Deposited 2017-11-19 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded ZN ZINC ION × 2 946 4-[(1~{R})-2-(naphthalen-2-ylmethylamino)-1-oxidanyl-ethyl]benzene-1,2-diol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;sodium citrate, pH 6.0
Resolution 1.90 Å R-free 0.215
5YTO Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound. Deposited 2017-11-19 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;sodium citrate, pH 6.0
Resolution 1.90 Å R-free 0.215
5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group Deposited 2017-11-20 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded 5FW ISOPRENALINE × 1 ZN ZINC ION × 2 TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1 S4P Dihydrogen tetrasulfide × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate, pH 6.0
Resolution 1.90 Å R-free 0.221
5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group Deposited 2017-11-20 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate, pH 6.0
Resolution 1.90 Å R-free 0.221
5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group Deposited 2017-11-20 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–154(154 aa)
Chain E 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate, pH 6.0
Resolution 1.90 Å R-free 0.221
5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group Deposited 2017-11-20 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Chain G 1–154(154 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate, pH 6.0
Resolution 1.90 Å R-free 0.221
5YTU Structure of human SOD1 complexed with isoproteranol in C2221 space group Deposited 2017-11-20 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate, pH 6.0
Resolution 1.90 Å R-free 0.221
5YUL Native Structure of hSOD1 in P6322 space group Deposited 2017-11-22 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate pH 6.0
Resolution 1.90 Å R-free 0.227
5YUL Native Structure of hSOD1 in P6322 space group Deposited 2017-11-22 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate pH 6.0
Resolution 1.90 Å R-free 0.227
5YUL Native Structure of hSOD1 in P6322 space group Deposited 2017-11-22 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–154(154 aa)
Chain E 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate pH 6.0
Resolution 1.90 Å R-free 0.227
5YUL Native Structure of hSOD1 in P6322 space group Deposited 2017-11-22 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Chain G 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate pH 6.0
Resolution 1.90 Å R-free 0.227
5YUL Native Structure of hSOD1 in P6322 space group Deposited 2017-11-22 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 1 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;300 K;Sodium Citrate pH 6.0
Resolution 1.90 Å R-free 0.227
6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis Deposited 2018-07-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 DMS DIMETHYL SULFOXIDE × 1 GOL GLYCEROL × 2 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.5M Sodium Citrate, pH 6.0
Resolution 2.50 Å R-free 0.237
6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis Deposited 2018-07-14 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded ZN ZINC ION × 2 DMS DIMETHYL SULFOXIDE × 1 GOL GLYCEROL × 2 S4P Dihydrogen tetrasulfide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.5M Sodium Citrate, pH 6.0
Resolution 2.50 Å R-free 0.237
6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis Deposited 2018-07-14 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded ZN ZINC ION × 2 S4P Dihydrogen tetrasulfide × 1 6B3 2'-[(6-oxo-5,6-dihydrophenanthridin-3-yl)carbamoyl][1,1'-biphenyl]-2-carboxylic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.5M Sodium Citrate, pH 6.0
Resolution 2.50 Å R-free 0.237
6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis Deposited 2018-07-14 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.5M Sodium Citrate, pH 6.0
Resolution 2.50 Å R-free 0.237
6A9O Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis Deposited 2018-07-14 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.5M Sodium Citrate, pH 6.0
Resolution 2.50 Å R-free 0.237
6B79 Curved pair of sheets formed from SOD1 residues 28-38 with familial mutation G37R. Deposited 2017-10-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 8 PDB declaration: octameric(8) Consistent with protein count
Chain A 29–39(11 aa)
Chain B 29–39(11 aa)
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) ORA 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;HEPES pH 7.5, Sodium citrate, 2-Methyl-2,4-pentanediol
Resolution 1.80 Å R-free 0.267
6DTK Heterodimers of FALS mutant SOD enzyme Deposited 2018-06-17 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–154(154 aa)
Chain A 2–154(153 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;2-3 M Ammonium sulfate or Sodium malonate
Resolution 2.00 Å R-free 0.190
6DTK Heterodimers of FALS mutant SOD enzyme Deposited 2018-06-17 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 1–154(154 aa)
Chain C 2–154(153 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;2-3 M Ammonium sulfate or Sodium malonate
Resolution 2.00 Å R-free 0.190
6DTK Heterodimers of FALS mutant SOD enzyme Deposited 2018-06-17 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain E 1–154(154 aa)
Chain E 2–154(153 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 MLI MALONATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;2-3 M Ammonium sulfate or Sodium malonate
Resolution 2.00 Å R-free 0.190
6DTK Heterodimers of FALS mutant SOD enzyme Deposited 2018-06-17 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain G 1–154(154 aa)
Chain G 2–154(153 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;2-3 M Ammonium sulfate or Sodium malonate
Resolution 2.00 Å R-free 0.190
6DTK Heterodimers of FALS mutant SOD enzyme Deposited 2018-06-17 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain I 1–154(154 aa)
Chain I 2–154(153 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;2-3 M Ammonium sulfate or Sodium malonate
Resolution 2.00 Å R-free 0.190
6FFK Human apo-SOD1 bound to PtCl2(1R,2R-1,4-DACH Deposited 2018-01-08 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded D7Z PtCl2(1(R),2(R)-DACH) × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1 M HEPES, 20% PEG 3350
Resolution 1.94 Å R-free 0.256
6FFK Human apo-SOD1 bound to PtCl2(1R,2R-1,4-DACH Deposited 2018-01-08 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded D7Z PtCl2(1(R),2(R)-DACH) × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1 M HEPES, 20% PEG 3350
Resolution 1.94 Å R-free 0.256
6FLH Monomeric Human Cu,Zn Superoxide dismutase, SOD1 7+7, apo form Deposited 2018-01-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded SO4 SULFATE ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium acetate pH 4.6 and 2 M ammonium sulfate
Resolution 1.79 Å R-free 0.197
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 2–154(153 aa)
Chain G 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain K 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain M 2–154(153 aa)
Chain O 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Q 2–154(153 aa)
Chain S 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOI Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated. Deposited 2018-02-07 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain U 2–154(153 aa)
Chain W 2–154(153 aa)
Not recorded ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.2 M Lithium sulphate 24% w/v PEG 4000 0.1 M Tris-HCl pH 8.0
Resolution 2.00 Å R-free 0.259
6FOL Domain II of the human copper chaperone in complex with human Cu,Zn superoxide dismutase Deposited 2018-02-07 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;25% (w/v) PEG 1500 and 0.1 M PCTP buffer pH 7.0 (sodium propionate, sodium cacodylate, and BIS-TRIS propane in the molar ratios 2:1:2, respectively)
Resolution 2.55 Å R-free 0.248
6FOL Domain II of the human copper chaperone in complex with human Cu,Zn superoxide dismutase Deposited 2018-02-07 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 PE8 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;25% (w/v) PEG 1500 and 0.1 M PCTP buffer pH 7.0 (sodium propionate, sodium cacodylate, and BIS-TRIS propane in the molar ratios 2:1:2, respectively)
Resolution 2.55 Å R-free 0.248
6FOL Domain II of the human copper chaperone in complex with human Cu,Zn superoxide dismutase Deposited 2018-02-07 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;25% (w/v) PEG 1500 and 0.1 M PCTP buffer pH 7.0 (sodium propionate, sodium cacodylate, and BIS-TRIS propane in the molar ratios 2:1:2, respectively)
Resolution 2.55 Å R-free 0.248
6FOL Domain II of the human copper chaperone in complex with human Cu,Zn superoxide dismutase Deposited 2018-02-07 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;25% (w/v) PEG 1500 and 0.1 M PCTP buffer pH 7.0 (sodium propionate, sodium cacodylate, and BIS-TRIS propane in the molar ratios 2:1:2, respectively)
Resolution 2.55 Å R-free 0.248
6FON Elongated conformer of the human copper chaperone for SOD1 complexed with human SOD1 Deposited 2018-02-07 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 2–154(153 aa)
Chain D 2–154(153 aa)
Not recorded ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1 M MES pH 6.0 0.2 M Magnesium chloride 20 % (w/v) PEG 6000
Resolution 3.05 Å R-free 0.246
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 PPI PROPANOIC ACID × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 10 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain S 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 11 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain U 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 12 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain W 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 PPI PROPANOIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 PPI PROPANOIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain M 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain O 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6FP6 Complex of human Cu,Zn SOD1 with the human copper chaperone for SOD1 in a compact conformation Deposited 2018-02-09 Assembly 9 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Q 2–154(153 aa)
Mutation:C57A; C146A ZN ZINC ION × 2 PPI PROPANOIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M PCTP buffer pH 9.0, 20% (w/v) PEG 3350.
Resolution 3.00 Å R-free 0.230
6SPA A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 IN C2 SPACE GROUP Deposited 2019-08-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain C 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 GOL GLYCEROL × 4 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 1.65 Å R-free 0.196
6SPA A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 IN C2 SPACE GROUP Deposited 2019-08-31 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain G 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 GOL GLYCEROL × 6 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 1.65 Å R-free 0.196
6SPA A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 IN C2 SPACE GROUP Deposited 2019-08-31 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 2–154(153 aa)
Chain L 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 GOL GLYCEROL × 2 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 1.65 Å R-free 0.196
6SPH A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 WITH EBSELEN BOND IN C2 SPACE GROUP Deposited 2019-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain C 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 9JT N-phenyl-2-selanylbenzamide × 2 GOL GLYCEROL × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 2.25 Å R-free 0.222
6SPH A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 WITH EBSELEN BOND IN C2 SPACE GROUP Deposited 2019-09-01 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain G 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 9JT N-phenyl-2-selanylbenzamide × 2 GOL GLYCEROL × 3 SO4 SULFATE ION × 1 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 2.25 Å R-free 0.222
6SPH A4V MUTANT OF HUMAN SUPEROXIDE DISMUTASE 1 WITH EBSELEN BOND IN C2 SPACE GROUP Deposited 2019-09-01 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 2–154(153 aa)
Chain L 2–154(153 aa)
Mutation:Ala4Val Mutation:Ala4Val ZN ZINC ION × 2 9JT N-phenyl-2-selanylbenzamide × 2 GOL GLYCEROL × 2 SO4 SULFATE ION × 1 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Tris-HCl pH 7.4-8.0, 2.4-2.6 M ammonium sulphate, 150 mM NaCl
Resolution 2.25 Å R-free 0.222
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain J 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1–154(154 aa)
Chain K 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain I 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–154(154 aa)
Chain L 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain G 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPI A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 4 Deposited 2019-09-01 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Chain H 1–154(154 aa)
Mutation:A4V Mutation:A4V LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;100mM Tris-HCl pH 7.8, 2.6 M ammonium sulphate
Resolution 2.80 Å R-free 0.241
6SPJ A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 1 Deposited 2019-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 LR2 ~{N}-pyridin-2-yl-2-selanyl-benzamide × 2 SO4 SULFATE ION × 13 GOL GLYCEROL × 2 DMS DIMETHYL SULFOXIDE × 3 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 1.97 Å R-free 0.225
6SPJ A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 1 Deposited 2019-09-01 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 LR2 ~{N}-pyridin-2-yl-2-selanyl-benzamide × 2 SO4 SULFATE ION × 7 GOL GLYCEROL × 2 DMS DIMETHYL SULFOXIDE × 4 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 1.97 Å R-free 0.225
6SPJ A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 1 Deposited 2019-09-01 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain J 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 LR2 ~{N}-pyridin-2-yl-2-selanyl-benzamide × 2 SO4 SULFATE ION × 10 GOL GLYCEROL × 2 DMS DIMETHYL SULFOXIDE × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 1.97 Å R-free 0.225
6SPK A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 6 Deposited 2019-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 2 LQN 2-selanyl-~{N}-[3-[4-(trifluoromethyl)phenyl]phenyl]benzamide × 2 SO4 SULFATE ION × 8 GOL GLYCEROL × 1 CL CHLORIDE ION × 3 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 2.77 Å R-free 0.229
6SPK A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 6 Deposited 2019-09-01 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 2 LQN 2-selanyl-~{N}-[3-[4-(trifluoromethyl)phenyl]phenyl]benzamide × 2 SO4 SULFATE ION × 10 CL CHLORIDE ION × 3 DMS DIMETHYL SULFOXIDE × 2 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 2.77 Å R-free 0.229
6SPK A4V MUTANT OF HUMAN SOD1 WITH EBSELEN DERIVATIVE 6 Deposited 2019-09-01 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Chain J 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 3 LQN 2-selanyl-~{N}-[3-[4-(trifluoromethyl)phenyl]phenyl]benzamide × 2 SO4 SULFATE ION × 8 CL CHLORIDE ION × 3 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;2.6 M Ammonium sulphate, 100 mM Tris-HCl pH 7.6, 150 mM NaCl
Resolution 2.77 Å R-free 0.229
6Z3V A4V mutant of human SOD1 bound with N-aryl benzoisoselenazolone derivative 13 in P21 space group Deposited 2020-05-22 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 Q6H 5-fluoranyl-~{N}-(3-morpholin-4-ylcarbonylphenyl)-2-selanyl-benzamide × 2 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.25 Å R-free 0.191
6Z4G A4V mutant of human SOD1 bound with ebselen in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 ACT ACETATE ION × 2 9JT N-phenyl-2-selanylbenzamide × 2 SO4 SULFATE ION × 4 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.45 Å R-free 0.193
6Z4H A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 2 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 LQW ~{N}-[(4-chlorophenyl)methyl]-2-selanyl-benzamide × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.6M ammonium sulphate
Resolution 1.95 Å R-free 0.242
6Z4I A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 3 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain FFF 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 ACT ACETATE ION × 2 SO4 SULFATE ION × 2 Q85 ~{N}-[(4-methoxyphenyl)methyl]-2-selanyl-benzamide × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.60 Å R-free 0.217
6Z4J A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 5 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 Q7W ~{N}-[(3-chlorophenyl)methyl]-2-selanyl-benzamide × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.5M ammonium sulphate
Resolution 1.55 Å R-free 0.208
6Z4K A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 6 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V Q7N ~{N}-[(3-methoxyphenyl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 4 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.45 Å R-free 0.209
6Z4L A4V mutant of human SOD1 bound with 2-(pyridin-3-ylmethyl)benzoisoselenazolone derivative 9 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V Q8H ~{N}-(pyridin-3-ylmethyl)-2-selanyl-benzamide × 2 ZN ZINC ION × 4 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.60 Å R-free 0.208
6Z4M A4V mutant of human SOD1 bound with 2-(pyridin-3-ylmethyl)benzoisoselenazolone derivative 10 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V Q8E ~{N}-[(6-methoxypyridin-3-yl)methyl]-2-selanyl-benzamide × 2 ZN ZINC ION × 4 CL CHLORIDE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.55 Å R-free 0.208
6Z4O A4V mutant of human SOD1 bound with benzyl benzoisoselenazolone derivative 1 in P21 space group Deposited 2020-05-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain AAA 2–154(153 aa)
Chain BBB 2–154(153 aa)
Mutation:A4V Mutation:A4V ZN ZINC ION × 4 Q7T ~{N}-(phenylmethyl)-2-selanyl-benzamide × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.40 Å R-free 0.232
7FB6 C57D/C146D mutant of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–154(154 aa)
Mutation:C57D/C146D Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 1 CU COPPER (II) ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.2M MgCl2, 22% (w/v) PEG 3350
Resolution 1.80 Å R-free 0.213
7FB6 C57D/C146D mutant of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 1–154(154 aa)
Mutation:C57D/C146D Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 1 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.2M MgCl2, 22% (w/v) PEG 3350
Resolution 1.80 Å R-free 0.213
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain I 1–154(154 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1–154(154 aa)
Chain E 1–154(154 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Chain G 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain H 1–154(154 aa)
Chain L 1–154(154 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 1–154(154 aa)
Chain K 1–154(154 aa)
Not recorded ZN ZINC ION × 2 CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain M 1–154(154 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7FB9 Crystal Structure of Human Cu, Zn Superoxide Dismutase (SOD1) Deposited 2021-07-08 Assembly 8 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain N 1–154(154 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;287.15 K;0.1M sodium acetate-HCl (pH 4.5), 21% (w/v) PEG 3350
Resolution 2.70 Å R-free 0.247
7NXX Structure of Superoxide Dismutase 1 (SOD1) in complex with nanobody 2 (Nb2). Deposited 2021-03-19 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;273 K;0.1 M Hepes,1.5 M Lithium sulphate, pH 7.5
Resolution 2.19 Å R-free 0.245
7T8E G93A mutant of human SOD1 in P21 space group Deposited 2021-12-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 4 ACT ACETATE ION × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.40 Å R-free 0.229
7T8F G93A mutant of human SOD1 bound with Ebselen in P21 space group Deposited 2021-12-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 4 ACT ACETATE ION × 1 9JT N-phenyl-2-selanylbenzamide × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.40 Å R-free 0.225
7T8G G93A mutant of human SOD1 bound with MR6-8-2 in P21 space group Deposited 2021-12-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 4 Q8H ~{N}-(pyridin-3-ylmethyl)-2-selanyl-benzamide × 2 ACT ACETATE ION × 1 SO4 SULFATE ION × 2 SE SELENIUM ATOM × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.35 Å R-free 0.202
7T8H G93A mutant of human SOD1 bound with MR6-26-2 in P21 space group Deposited 2021-12-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain F 2–154(153 aa)
Mutation:G93A Mutation:G93A ZN ZINC ION × 4 ACT ACETATE ION × 1 Q8E ~{N}-[(6-methoxypyridin-3-yl)methyl]-2-selanyl-benzamide × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.7;292 K;100mM NaOAc pH 4.7, 150mM NaCl, 2.7M ammonium sulphate
Resolution 1.50 Å R-free 0.224
7VZF Cryo-EM structure of amyloid fibril formed by full-length human SOD1 Deposited 2021-11-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.95 Å
7XX3 Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB) Deposited 2022-05-28 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 4 I2G (2~{E},4~{E},6~{S})-4,6-dimethyldeca-2,4-dienoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate (pH = 6.5)
Resolution 1.90 Å R-free 0.230
7XX3 Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB) Deposited 2022-05-28 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 1 I2G (2~{E},4~{E},6~{S})-4,6-dimethyldeca-2,4-dienoic acid × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate (pH = 6.5)
Resolution 1.90 Å R-free 0.230
7XX3 Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB) Deposited 2022-05-28 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded ZN ZINC ION × 2 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate (pH = 6.5)
Resolution 1.90 Å R-free 0.230
7XX3 Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB) Deposited 2022-05-28 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Chain G 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate (pH = 6.5)
Resolution 1.90 Å R-free 0.230
7XX3 Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB) Deposited 2022-05-28 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 1 I2G (2~{E},4~{E},6~{S})-4,6-dimethyldeca-2,4-dienoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate (pH = 6.5)
Resolution 1.90 Å R-free 0.230
8CCX Human SOD1 in complex with S-XL6 cross-linker Deposited 2023-01-27 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 4 SO4 SULFATE ION × 2 UDI butane-1,4-dithiol × 1 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.75;293 K;2.5M ammonium sulphate, 150mM NaCl, sodium acetate pH 4.75
Resolution 1.67 Å R-free 0.233
8GSQ Structure based studies reveal an atypical antipsychotic drug candidate - Paliperidone as a potent hSOD1 modulator with implications in ALS treatment. Deposited 2022-09-06 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Citrate
Resolution 2.10 Å R-free 0.208
8GSQ Structure based studies reveal an atypical antipsychotic drug candidate - Paliperidone as a potent hSOD1 modulator with implications in ALS treatment. Deposited 2022-09-06 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Citrate
Resolution 2.10 Å R-free 0.208
8GSQ Structure based studies reveal an atypical antipsychotic drug candidate - Paliperidone as a potent hSOD1 modulator with implications in ALS treatment. Deposited 2022-09-06 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Citrate
Resolution 2.10 Å R-free 0.208
8GSQ Structure based studies reveal an atypical antipsychotic drug candidate - Paliperidone as a potent hSOD1 modulator with implications in ALS treatment. Deposited 2022-09-06 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Sodium Citrate
Resolution 2.10 Å R-free 0.208
8IHU Cryo-EM structure of an amyloid fibril formed by ALS-causing SOD1 mutation G85R Deposited 2023-02-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.97 Å
8IHV Cryo-EM structure of an amyloid fibril formed by ALS-causing SOD1 mutation H46R Deposited 2023-02-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.11 Å
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 10 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain Y 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 11 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain U 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 12 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain W 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 5 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 6 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 7 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain L 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 8 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain N 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K33 SOD1 and Nanobody1 complex Deposited 2023-07-14 Assembly 9 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain P 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 8.5;291 K;0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350
Resolution 2.13 Å R-free 0.265
8K3A SOD1 and Nanobody2 complex Deposited 2023-07-14 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Magnesium chloride, 0.1 M Sodium, citrate pH 5, 15%(w/v) PEG 4000
Resolution 2.74 Å R-free 0.256
8K3L SOD1 and Nanobody3 complex Deposited 2023-07-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded CU COPPER (II) ION × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v Polyethylene, glycol monomethyl ether 2,000
Resolution 2.30 Å R-free 0.235
8K3L SOD1 and Nanobody3 complex Deposited 2023-07-16 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 2–154(153 aa)
Not recorded CU COPPER (II) ION × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v Polyethylene, glycol monomethyl ether 2,000
Resolution 2.30 Å R-free 0.235
8K3L SOD1 and Nanobody3 complex Deposited 2023-07-16 Assembly 3 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 2–154(153 aa)
Not recorded CU COPPER (II) ION × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v Polyethylene, glycol monomethyl ether 2,000
Resolution 2.30 Å R-free 0.235
8K3L SOD1 and Nanobody3 complex Deposited 2023-07-16 Assembly 4 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 2–154(153 aa)
Not recorded CU COPPER (II) ION × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v Polyethylene, glycol monomethyl ether 2,000
Resolution 2.30 Å R-free 0.235
8Q6M Human SOD1 low dose data collecton Deposited 2023-08-14 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ACT ACETATE ION × 1 ZN ZINC ION × 2 CU COPPER (II) ION × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 4.75;293 K;2.5 M Ammonium sulphate, Acetate buffer pH 4.75
Resolution 1.77 Å R-free 0.251
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain D 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain H 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain L 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 5 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain P 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAF SOD1, Nanobody1 and Nanobody2 complex Deposited 2024-02-09 Assembly 6 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain T 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;5% (v/v) Isopropanol, 2.0 M Ammonium sulfate
Resolution 3.28 Å R-free 0.249
8YAT SOD1, Nanobody1, Nanobody2 and Nanobody3 complex Deposited 2024-02-10 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2M Ammonium sulfate, 0.1M HEPES pH8.0, 20%w/v Polyethylene glycol 3350
Resolution 3.94 Å R-free 0.368
8YAT SOD1, Nanobody1, Nanobody2 and Nanobody3 complex Deposited 2024-02-10 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain E 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2M Ammonium sulfate, 0.1M HEPES pH8.0, 20%w/v Polyethylene glycol 3350
Resolution 3.94 Å R-free 0.368
8YAT SOD1, Nanobody1, Nanobody2 and Nanobody3 complex Deposited 2024-02-10 Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain I 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2M Ammonium sulfate, 0.1M HEPES pH8.0, 20%w/v Polyethylene glycol 3350
Resolution 3.94 Å R-free 0.368
8YAT SOD1, Nanobody1, Nanobody2 and Nanobody3 complex Deposited 2024-02-10 Assembly 4 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain M 2–154(153 aa)
Not recorded ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;0.2M Ammonium sulfate, 0.1M HEPES pH8.0, 20%w/v Polyethylene glycol 3350
Resolution 3.94 Å R-free 0.368
8YD3 Crystal structure of human Cu-Zn Superoxide Dismutase 1 in complex with 1,2,10-Decanetriol Deposited 2024-02-19 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 A1LYN (2S)-decane-1,2,10-triol × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate
Resolution 1.96 Å R-free 0.211
8YD3 Crystal structure of human Cu-Zn Superoxide Dismutase 1 in complex with 1,2,10-Decanetriol Deposited 2024-02-19 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 2 A1LYN (2S)-decane-1,2,10-triol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate
Resolution 1.96 Å R-free 0.211
8YD3 Crystal structure of human Cu-Zn Superoxide Dismutase 1 in complex with 1,2,10-Decanetriol Deposited 2024-02-19 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded ZN ZINC ION × 2 GOL GLYCEROL × 1 A1LYN (2S)-decane-1,2,10-triol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate
Resolution 1.96 Å R-free 0.211
8YD3 Crystal structure of human Cu-Zn Superoxide Dismutase 1 in complex with 1,2,10-Decanetriol Deposited 2024-02-19 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded ZN ZINC ION × 1 A1LYN (2S)-decane-1,2,10-triol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate
Resolution 1.96 Å R-free 0.211
8YD3 Crystal structure of human Cu-Zn Superoxide Dismutase 1 in complex with 1,2,10-Decanetriol Deposited 2024-02-19 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded ZN ZINC ION × 2 A1LYN (2S)-decane-1,2,10-triol × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;1.3 M Sodium citrate
Resolution 1.96 Å R-free 0.211
9IYD Cryo-EM structure of an amyloid fibril formed by SOD1 mutant - G93A Deposited 2024-07-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Mutation:G94A Mutation:G94A Mutation:G94A No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.09 Å
9IYJ Cryo-EM structure of an amyloid fibril formed by SOD1 mutant - D101N Deposited 2024-07-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Chain C 2–154(153 aa)
Mutation:D102N Mutation:D102N Mutation:D102N No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.92 Å
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 3 ACT ACETATE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 ACT ACETATE ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 1–154(154 aa)
Chain L 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 1–154(154 aa)
Chain H 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9IYK Crystal structure of hSOD1 in C121 space group Deposited 2024-07-30 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–154(154 aa)
Chain J 1–154(154 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate
Resolution 2.34 Å R-free 0.263
9JBO Cryo-EM structure of human SOD1 (WT) amyloid filament Deposited 2024-08-27 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.39 Å
9JBP Cryo-EM structure of human SOD1 (C6A/C111A) amyloid filament Deposited 2024-08-27 Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Chain D 1–154(154 aa)
Chain E 1–154(154 aa)
Chain F 1–154(154 aa)
Mutation:C6A,C111A Mutation:C6A,C111A Mutation:C6A,C111A Mutation:C6A,C111A Mutation:C6A,C111A Mutation:C6A,C111A No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.18 Å
9LI1 Cryo-EM structure of human SOD1 (G93A) amyloid filament Deposited 2025-01-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–154(154 aa)
Chain B 1–154(154 aa)
Chain C 1–154(154 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.74 Å
9MIL Superoxide dismutase residues 28-39 with G37R mutation Deposited 2024-12-13 Assembly 1 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric(10) Consistent with protein count
Chain A 29–40(12 aa)
Chain B 29–40(12 aa)
Chain C 29–40(12 aa)
Chain D 29–40(12 aa)
Chain E 29–40(12 aa)
Chain F 29–40(12 aa)
Chain G 29–40(12 aa)
Chain H 29–40(12 aa)
Chain I 29–40(12 aa)
Chain J 29–40(12 aa)
Not recorded SO4 SULFATE ION × 5 PG4 TETRAETHYLENE GLYCOL × 2 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.0 M Ammonium sulfate, 0.1 M BIS-TRIS pH 5.5, 1% w/v Polyethylene glycol 3,350
Resolution 2.50 Å R-free 0.263
9XJ0 Crystal structure of SOD1 by serial synchrotron crystallography Deposited 2025-11-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate, PVP-K15
Resolution 2.30 Å R-free 0.210
9XJI Cryogenic structure of SOD1, determined as the SSX counterpart Deposited 2025-11-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–154(153 aa)
Chain B 2–154(153 aa)
Not recorded CU COPPER (II) ION × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium acetate, PVP-K15
Resolution 2.37 Å R-free 0.231